Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongmai Jiangtang Capsule for diabetic coronary heart disease with damp-heat collateral obstruction
ChiCTR2000037491Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Shaanxi University of Chinese Medicine
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongmai Jiangtang Capsule in type 2 diabetes mellitus (T2DM), coronary arteriosclerosis and stable angina (2 arms), sponsored by Affiliated Hospital of Shaanxi University of Chinese Medicine. Primary endpoints: CCS classification of stable angina and Treadmill test. Planned start May 2020; status: not yet recruiting.
02
Drugs
Tongmai Jiangtang Capsule
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR2000037491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037491.